Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir by BY GINA KOLATA


Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.

Published: April 29, 2020 at 03:43PM

from NYT Health https://ift.tt/2yYBdr9